| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net Income (Loss) Attributable to Parent | ||||||
27,143 | 28,020 | -17,499 | -24,258 | -21,450 | -20,329 | |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||
Depreciation and amortization | ||||||
8,292 | 5,218 | 3,484 | 1,677 | 759 | 345 | |
Non-cash operating lease cost | ||||||
5,088 | - | - | - | - | - | |
Stock-based compensation | ||||||
33,125 | 16,647 | 8,886 | 3,284 | 1,482 | 10,677 | |
Amortization (accretion) of discounts and premiums on investments, net | ||||||
3,030 | 1,382 | -473 | - | - | - | |
Amortization of debt discount and issuance costs | ||||||
18,625 | 6,652 | 0 | 0 | - | - | |
Provision for doubtful accounts, net of recoveries | ||||||
- | - | - | 432 | 380 | -38 | |
Deferred income taxes | ||||||
22,844 | 3,434 | 1,425 | 27 | 12 | 1 | |
Provision for doubtful accounts, net of recoveries | ||||||
- | - | - | 770 | - | - | |
Deferred income taxes | ||||||
- | - | - | -27 | - | - | |
Gain (Loss) on Extinguishment of Debt | ||||||
-20,507 | 0 | 0 | - | - | - | |
Other non-cash operating activities, net | ||||||
1,328 | -1,024 | -2,235 | - | - | - | |
Impairment of long-lived assets | ||||||
- | - | - | 0 | - | - | |
Change in fair value of contingent consideration | ||||||
- | - | - | 0 | - | - | |
Loss on disposal of assets | ||||||
- | - | - | -66 | -47 | -7 | |
Changes in operating assets and liabilities, net of effect of business acquisitions: | ||||||
Accounts receivable | ||||||
35,325 | 45,640 | 15,325 | 14,248 | 6,216 | 2,718 | |
Deferred commissions | ||||||
20,461 | 12,741 | 3,663 | 1,582 | -2,233 | -1,563 | |
Prepaid expenses and other current assets and other assets | ||||||
34,971 | 16,077 | 3,508 | 4,314 | 768 | 750 | |
Accounts payable | ||||||
2,319 | 4,530 | -1,483 | 2,134 | -802 | 590 | |
Accrued payroll and payroll related liabilities | ||||||
28,651 | 12,898 | 4,047 | 1,177 | 2,744 | 1,344 | |
Accrued expenses, other current liabilities, operating lease liabilities, and other liabilities | ||||||
8,091 | 1,315 | 3,048 | 1,123 | 1,908 | -210 | |
Deferred revenue | ||||||
310 | 29,059 | 39,835 | 27,840 | 15,252 | 8,511 | |
Other liabilities | ||||||
- | - | - | 666 | 874 | 707 | |
Net cash provided by operating activities | ||||||
34,192 | 26,089 | 19,105 | -6,030 | -8,035 | -3,428 | |
Cash flows from investing activities: | ||||||
Purchases of property and equipment | ||||||
11,453 | 6,728 | 3,669 | 4,307 | 2,714 | 531 | |
Cash paid in business acquisitions, net of cash acquired | ||||||
40,949 | 3,537 | 9,097 | 0 | - | - | |
Purchases of investments | ||||||
602,703 | 445,705 | 91,517 | 5,720 | 36,445 | - | |
Sales and maturities of investments | ||||||
377,974 | 185,112 | 37,862 | 20,762 | - | - | |
Purchase of cost method investment | ||||||
- | - | - | - | - | 1,050 | |
Change in restricted cash | ||||||
- | - | - | - | 1,200 | - | |
Net cash provided by (used in) investing activities | ||||||
-277,131 | -270,858 | -66,421 | 10,735 | -40,359 | -1,581 | |
Cash flows from financing activities: | ||||||
Proceeds from issuance of Notes, net of issuance costs | ||||||
783,321 | 224,246 | 0 | - | - | - | |
Principal payments on 2023 Notes | ||||||
145,241 | 0 | 0 | - | - | - | |
Proceeds from issuance of convertible senior notes, net of issuance costs | ||||||
- | - | - | 0 | - | - | |
Payment For Purchase Of Capped Calls | ||||||
- | - | - | 0 | - | - | |
Purchase of capped calls | ||||||
87,360 | 19,113 | 0 | - | - | - | |
Proceeds from receipt of Section 16(b) disgorgement | ||||||
4,918 | 0 | 0 | - | - | - | |
Proceeds from initial public offering, net of underwriting commissions and discounts | ||||||
0 | 0 | 134,757 | 0 | - | - | |
Payments associated with issuance of Series C convertible preferred stock | ||||||
- | - | - | 350 | - | - | |
Proceeds from issuance of Series C convertible preferred stock, net of issuance costs paid | ||||||
- | - | - | - | 49,575 | - | |
Proceeds from issuance of common stock | ||||||
- | - | - | - | 35,000 | - | |
Payment of initial public offering costs | ||||||
0 | 0 | 2,396 | 948 | - | - | |
Repurchase of common stock, net of costs paid | ||||||
- | - | - | 256 | 34,756 | 240 | |
Advance from line of credit | ||||||
- | - | - | - | 1,875 | - | |
Repayment of line of credit | ||||||
- | - | - | - | 3,875 | - | |
Loans to stockholders | ||||||
- | - | - | - | - | 466 | |
Accrued expenses and other current liabilities | ||||||
- | - | - | 2,237 | - | 146 | |
Payment of holdback funds from acquisition | ||||||
- | - | - | 0 | - | - | |
Proceeds from issuance of Series B convertible preferred stock, net of issuance costs paid | ||||||
- | - | - | - | - | 19,914 | |
Principal payments on capital lease obligations | ||||||
- | - | - | 274 | - | - | |
Proceeds from exercise of stock options and taxes withheld | ||||||
20,156 | 14,154 | 4,342 | 413 | 686 | 1,339 | |
Minimum tax withholding paid on behalf of employees for restricted stock units | ||||||
10,643 | 2,730 | 674 | 0 | - | - | |
Other financing activity | ||||||
-1,305 | -577 | -328 | - | - | - | |
Excess tax benefit from stock-based compensation | ||||||
- | - | - | - | 26 | - | |
Net cash provided by financing activities | ||||||
563,846 | 215,980 | 135,701 | 822 | 48,531 | 20,693 | |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||
-444 | -166 | 25 | 0 | - | - | |
Net increase (decrease) in cash, cash equivalents and restricted cash | ||||||
320,463 | -28,955 | 88,410 | 5,527 | 137 | 15,684 | |
Supplemental disclosure of cash flow information: | ||||||
Cash paid for interest | ||||||
930 | 617 | 0 | 0 | 101 | 66 | |
Cash paid for income taxes | ||||||
1,630 | 1,782 | 333 | 12 | 7 | 10 | |
Supplemental disclosure of noncash investing and financing activities: | ||||||
Property and equipment recorded in accounts payable and accrued expenses and other current liabilities | ||||||
2,002 | 720 | 0 | 38 | 27 | 16 | |
Right-of-use assets obtained in exchange for new operating lease liabilities | ||||||
13,312 | - | - | - | - | - | |
Consideration for business acquisition included in accrued expenses and other current liabilities and other liabilities | ||||||
3,000 | 1,200 | 1,660 | 0 | - | - | |
Deferred initial public offering costs recorded in accounts payable and accrued expenses | ||||||
- | - | - | 452 | - | - | |
Contingent consideration settled through issuance of common stock | ||||||
750 | 656 | 375 | 0 | - | - | |
Conversion of Series A redeemable convertible preferred stock to common shares | ||||||
0 | 0 | 101,165 | 0 | 706 | - | |
Consideration for business acquisition from issuance of common stock | ||||||
0 | 0 | 5,285 | 0 | - | - | |
Accretion of Series A redeemable convertible preferred stock | ||||||
0 | 0 | 1,983 | 6,442 | 2,603 | 1,669 | |
Property and equipment funded by capital lease borrowing | ||||||
- | - | - | 987 | - | - | |
Repurchase of common stock costs recorded in accrued expenses and other current liabilities | ||||||
- | - | - | - | 250 | - | |